Notice2022-01826
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 31, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Emerging Infections Program (EIP). EIP is a population-based surveillance system designed to collect information via active, laboratory case finding that is used for detecting, identifying, and monitoring emerging pathogens.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 20 (Monday, January 31, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Pages 4891-4893]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01826]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-0978; Docket No. CDC-2022-0012]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Emerging Infections Program
(EIP). EIP is a population-based surveillance system designed to
collect information via active, laboratory case finding that is used
for detecting, identifying, and monitoring emerging pathogens.
DATES: CDC must receive written comments on or before April 1, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0012 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://Regulations.gov">Regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#b7d8dad5f7d4d3d499d0d8c1"><span class="__cf_email__" data-cfemail="5d32303f1d3e393e733a322b">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information,
[[Page 4892]]
including the validity of the methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Emerging Infections Program (EIP) (OMB Control No. 0920-0978, Exp.
4/30/2022)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases.
Activities of the EIPs fall into the following general categories:
(1) Active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies. Activities of the EIPs are designed to: (1) Address
issues that the EIP network is particularly suited to investigate; (2)
maintain sufficient flexibility for emergency response and new problems
as they arise; (3) develop and evaluate public health interventions to
inform public health policy and treatment guidelines; (4) incorporate
training as a key function; and (5) prioritize projects that lead
directly to the prevention of disease.
A Revision is being submitted to make existing collection
instruments clearer and to add several new forms specifically surveying
laboratory practices. These forms will allow the EIP to better detect,
identify, track changes in laboratory testing methodology, gather
information about laboratory utilization in the EIP catchment area to
ensure that all cases are being captured, and survey EIP staff to
evaluate program quality.
CDC requests OMB approval for an estimated burden of 61,956 hours.
There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department....... ABCs Case Report 10 809 20/60 2,697
Form. 10 127 10/60 212
ABCs Invasive
Pneumococcal
Disease in
Children and
Adults Case
Report Form.
ABCs H. 10 6 10/60 10
influenzae
Neonatal Sepsis
Expanded
Surveillance
Form.
ABCs Severe GAS 10 136 20/60 453
Infection
Supplemental
Form.
ABCs Neonatal 10 37 20/60 123
Infection
Expanded
Tracking Form.
FoodNet 10 970 21/60 3,395
Campylobacter.
FoodNet 10 42 10/60 70
Cyclospora.
FoodNet Listeria 10 16 20/60 53
monocytogenes.
FoodNet 10 855 21/60 2,993
Salmonella.
FoodNet Shiga 10 290 20/60 967
toxin producing
E. coli.
FoodNet Shigella 10 234 10/60 390
FoodNet Vibrio.. 10 46 10/60 77
FoodNet Yersinia 10 55 10/60 92
FoodNet 10 10 1 100
Hemolytic
Uremic Syndrome
Case Report
Form.
FoodNet Clinical 10 70 20/60 233
Laboratory
Practices and
Testing Volume.
FluSurv-NET 10 764 25/60 3,183
Influenza
Hospitalization
Surveillance
Network Case
Report Form.
FluSurv-NET 10 333 5/60 278
Influenza
Hospitalization
Surveillance
Project
Vaccination
Phone Script
Consent Form
(English).
FluSurv-NET 10 333 5/60 278
Influenza
Hospitalization
Surveillance
Project
Vaccination
Phone Script
(Spanish).
Influenza 10 333 5/60 278
Hospitalization
Surveillance
Project
Provider
Vaccination
History Fax
Form (Children/
Adults).
FluSurv-NET 10 16 10/60 26
Laboratory
Survey.
[[Page 4893]]
HAIC--MuGSI Case 10 500 28/60 2,333
Report Form for
Carbapenem-
resistant
Enterobacteriac
eae (CRE) and
Acinetobacter
baumannii
(CRAB).
HAIC--MuGSI 10 4200 25/60 17,500
Extended-
Spectrum Beta-
Lactamase-
Producing
Enterobacteriac
eae (ESBL/iEC).
HAIC--Invasive 10 340 28/60 1,587
Methicillin-
resistant
Staphylococcus
aureus (MRSA)
Infection Case
Report Form.
HAIC--Invasive 10 584 28/60 2,725
Methicillin-
sensitive
Staphylococcus
aureus (MSSA)
Infection Case
Report Form.
HAIC--CDI Case 10 1650 38/60 10,450
Report and
Treatment Form.
HAIC Candidemia 10 200 30/60 1,134
Case Report.
HAIC--Annual 10 16 19/60 51
Survey of
Laboratory
Testing
Practices for
C. difficile
Infections.
HAIC--CDI Annual 10 1 15/60 3
Surveillance
Officers Survey.
HAIC--Emerging 10 45 5/60 38
Infections
Program C.
difficile
Surveillance
Nursing Home
Telephone
Survey (LTCF).
HAIC--Invasive 10 11 20/60 37
Staphylococcus
aureus
Laboratory
Survey.
HAIC--Invasive 10 1 10/60 17
Staphylococcus
aureus
Supplemental
Surveillance
Officers Survey.
HAIC--Laboratory 10 20 12/60 40
Testing
Practices for
Candidemia
Questionnaire.
HAIC MuGSI CA CP- 100 10 30/60 50
CRE Health
interview (new).
HAIC MuGSI 10 1 15/60 3
Supplemental
Surveillance
Officer Survey
(new).
HAIC Death 10 8 1440/60 10,080
Ascertainment
Variables.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 61,956
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-01826 Filed 1-28-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 31, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.